U.S., March 29 -- ClinicalTrials.gov registry received information related to the study (NCT06899529) titled 'Immediate Postoperative Bevacizumab Administration in Proliferative Diabetic Retinopathy Patients Undergoing Vitrectomy' on March 21.
Brief Summary: Patients undergoing surgery for complications related to diabetes will be recruited.
Study Start Date: March 20
Study Type: INTERVENTIONAL
Condition:
Proliferative Diabetic Retinopathy - High Risk
Intervention:
PROCEDURE: Bevacizumab
Bevacizumab will be given immediately after surgery in the Treatment Group
Recruitment Status: RECRUITING
Sponsor: Christian Ophthalmic Surgery Expedition Network
Disclaimer: Curated by HT Syndication....